Renaissance Technologies’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,700,438
Closed -$1.79M 3888
2020
Q4
$1.79M Sell
3,700,438
-123,908
-3% -$62.6K ﹤0.01% 2184
2020
Q3
$2.08M Sell
3,824,346
-487,717
-11% -$351K ﹤0.01% 2104
2020
Q2
$2.98M Sell
4,312,063
-25,210
-0.6% -$20.3K ﹤0.01% 1943
2020
Q1
$3.65M Buy
4,337,273
+169,988
+4% +$243K ﹤0.01% 1745
2019
Q4
$6.83M Buy
4,167,285
+245,755
+6% +$369K 0.01% 1678
2019
Q3
$4.35M Buy
3,921,530
+247,419
+7% +$286K ﹤0.01% 1872
2019
Q2
$4.56M Buy
3,674,111
+307,700
+9% +$392K ﹤0.01% 1864
2019
Q1
$4.85M Buy
3,366,411
+313,000
+10% +$464K ﹤0.01% 1831
2018
Q4
$3.6M Buy
3,053,411
+157,800
+5% +$234K ﹤0.01% 1932
2018
Q3
$3.91M Buy
2,895,611
+471,411
+19% +$747K ﹤0.01% 1953
2018
Q2
$5.55M Buy
2,424,200
+863,600
+55% +$1.67M 0.01% 1719
2018
Q1
$2.36M Buy
1,560,600
+366,500
+31% +$429K ﹤0.01% 2245
2017
Q4
$911K Buy
1,194,100
+346,400
+41% +$310K ﹤0.01% 2694
2017
Q3
$983K Sell
847,700
-19,000
-2% -$23.9K ﹤0.01% 2580
2017
Q2
$1.51M Buy
866,700
+179,700
+26% +$382K ﹤0.01% 2407
2017
Q1
$1.81M Buy
687,000
+369,400
+116% +$1.33M ﹤0.01% 2296
2016
Q4
$1.35M Buy
317,600
+200,200
+171% +$660K ﹤0.01% 2412
2016
Q3
$313K Buy
117,400
+105,000
+847% +$241K ﹤0.01% 2942
2016
Q2
$22K Sell
12,400
-19,700
-61% -$40.2K ﹤0.01% 3279
2016
Q1
$74K Sell
32,100
-255,378
-89% -$578K ﹤0.01% 3246
2015
Q4
$998K Buy
287,478
+9,878
+4% +$47.3K ﹤0.01% 2460
2015
Q3
$1.7M Buy
277,600
+23,700
+9% +$161K ﹤0.01% 2099
2015
Q2
$1.68M Buy
253,900
+40,900
+19% +$276K ﹤0.01% 2178
2015
Q1
$1.52M Buy
+213,000
New +$1.61M ﹤0.01% 2082

Other funds holding GEN

Renaissance Technologies's GEN Position: Q1 2021 in Review

Renaissance Technologies sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 3,700,438 shares — an estimated $1.79M sold.

Renaissance Technologies first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $6.83M in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Renaissance Technologies reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Renaissance Technologies sold 3,700,438 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $1.79M.
  • Renaissance Technologies first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
  • Renaissance Technologies's Genesis Healthcare, Inc. position peaked at $6.83M in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.